SAN FRANCISCO (GenomeWeb) – Adaptive Biotechnologies plans to become "the global leader" in immune profiling and designing customized therapeutics, according to CEO and Cofounder Chad Robins.
Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.